Introduction: Tru-cut biopsy is now one of the useful means of obtaining early and accurate histopathological diagnosis. It is easy and can be performed on an outpatient basis. It also avoids unnecessary excisional biopsy. It provides sufficient amount of tissue for pathologist to make an accurate histological diagnosis with its type, grade and degree of differentiation in majority of cases Aim: To study usefullness of trucut biopsy of palpable breast lesions in patients coming to a tertiary care hospital Objectives: 1. To correlate findings of trucut biopsy with histopathology of follow up surgical procedures. 2. To find sensitivity, specificity, positive predictive value, negative predictive value and overall diagnostic accuracy of trucut biopsy.
Introduction
Tru-cut biopsy of palpable breast lesions can provide all the reliable information to guide the surgeon and the oncologist to plan an ideal therapeutic strategy in surgical decision making. 1 And permits the eventual use of neoadjuvant therapy. 2 On the other hand excisional biopsy would provide the pathologist with the whole breast lesion and allows him or her to examine its histopathological type, grade and degree of differentiation of the carcinoma if present. Also receptor status for estrogen, progesterone and tyrosine kinas Her2 (C erb b2) can be assessed. However, it mostly requires general anesthesia. 3, 4 Aim To study usefullness of trucut biopsy of palpable breast lesions in patients coming to a tertiary care hospital www.jmscr.igmpublication.org Impact Factor (SJIF): 
Material and Methods
A prospective comparative study of two years conducted in Department of Pathology KHMRC. between June 2015 to June 2017. The study includes 106 patients of palpable breast lump. Trucut biopsy was performed using a Tru-Cut gun BARD MAX-CORE with an 18-gauge needle by means of 4 successive insertions with different angulations of the needle into the lesion's core.
Figure-1-Equipments required for trucut procedure

Result and Discussion
In the present study, majority of the patients (30.2%) were in the age group of 41-50 years followed by 23.6% in the age group of 51-60 years, 19.8% in the age group of 31-40 years, 14.2% in the age group of 21-30 years and 12.2% in the age group of >60 years. The most common clinical presentation in our study was a lump (90.7%) which was not associated with any other complaint (pain/ulcer) The left breast was affected in 52 (49%) patients while the right breast was affected in 53 (50%) patients. Bilateral involvement was observed in 1 (1%) patient. In maximum cases (60.4%), the lump measured between 3-5cms while in minimum (5.7%) cases, it measured <3 cms. 
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Discussion
In the present study, majority of the patients (30.2%) were in the age group of 41-50 years followed by 23.6% in the age group of 51-60 years, 19.8% in the age group of 31-40 years, 14.2% in the age group of 21-30 years and 12.2% in the age group of >60 years. Singh S et al 5 did a retrospective study of 104cases in which 2 patients were Males and rest 102 cases were Females. Age of the patients ranged from 15-65 years with mean age of 33yrs. It was observed in the present study that out of 106 patients, 15 7 , in a prospective study on fine needle aspiration cytology, trucut biopsy and final histopathological examination in breast lumps found of a total 70 breast lump aspirations, 36 breast lumps were benign and 34 breast lumps were malignant lumps. Of 36 breast lumps with benign lesions, 24(66.6%) were married. Rikabi et al 8 also reported benign neoplasm to be predominant lesion in their study.
Since the place of our study is tertiary care centre where patient presents with disease in advanced stage, which is the reason for disconcordance with other studies. In the present study, Trucut Biopsy findings correlated with the histopathological findings in 103 of 106 cases (97.2%), which included 29 of 30 (96.7%) of the benign lesions and 74 of 76 (97.4%) of the malignant lesions. 1 case was wrongly diagnosed as malignant while one case each was falsely diagnosed as benign and suspicious on Trucut Biopsy findings. The association was found to be statistically significant (p<0.05). Rikabi 
Correlation of Trucut Biopsy and Histopathological findings
post surgical specimen showed 75 (94.9%) malignant lesions and 4 benign lesions (5.1%).
Comparison of TCB to postsurgical histopathology revealed the following results: 74 true positive cases (93.7%), zero false positive cases (0%), one false negative case (1.3%) and 4 true negative cases (5.1%).
The one case falsely diagnosed as benign on trucut biopsy came out to be mucinous carcinoma on histopathology. Weaver MG et al. 10 In his study. Mucinous lesion of breast: A pathologic continuum. Reported that The diagnosis of mucinous carcinoma in core needle biopsy is uncomplicated if neoplastic epithelial cells are seen within the mucin. The diagnosis of mucocele like lesion with a frequently minimal epithelial component is more difficult. It is reasonable to view mucocele like lesions as a part of spectrum from benign through to mucinous carcinoma with a significant risk of underdiagnosis from the limited material present on core needle bioplsy. Excision of mucocele like lesions is therefore recommended. Rosen PP in his study Mucocele like tumors of the breast also reported that Mucocele like lesions must be considered in the differential diagnosis of mucinous carcinoma. 11 The case falsely diagnosed as malignant on trucut biopsy came out to be 13 concluded that Papillary carcinoma is the rare entity. differentiation between benign and malignant papillary lesions may be difficult on FNAC as well as trucut biopsy because both procedures targets the centre and invasion is at periphery. 
